References
- Ryu JS, Ryu HJ, Lee SN, Memon A, Lee SK, Nam HS, Kim HJ, Lee KH, Cho JH, Hwang SS. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer. J Clin Oncol 2014; 32:960 - 7; http://dx.doi.org/10.1200/JCO.2013.50.5453; PMID: 24550423
- Postmus PE, Brambilla E, Chansky K, Crowley J, Goldstraw P, Patz EF Jr., Yokomise H, International Association for the Study of Lung Cancer International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee, Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007; 2:686 - 93; http://dx.doi.org/10.1097/JTO.0b013e31811f4703; PMID: 17762334
- Maskell NA. Treatment options for malignant pleural effusions: patient preference does matter. JAMA 2012; 307:2432 - 3; http://dx.doi.org/10.1001/jama.2012.5543; PMID: 22609878
- Marazioti A, Blackwell TS, Stathopoulos GT. The lymphatic system in malignant pleural effusion. Drain or immune switch?. Am J Respir Crit Care Med 2014; 189:626 - 7; http://dx.doi.org/10.1164/rccm.201401-0140ED; PMID: 24628311
- Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med 2012; 186:487 - 92; http://dx.doi.org/10.1164/rccm.201203-0465PP; PMID: 22652027
- Stathopoulos GT, Kollintza A, Moschos C, Psallidas I, Sherrill TP, Pitsinos EN, Vassiliou S, Karatza M, Papiris SA, Graf D, et al. Tumor necrosis factor-alpha promotes malignant pleural effusion. Cancer Res 2007; 67:9825 - 34; http://dx.doi.org/10.1158/0008-5472.CAN-07-1064; PMID: 17942913
- Stathopoulos GT, Sherrill TP, Karabela SP, Goleniewska K, Kalomenidis I, Roussos C, Fingleton B, Yull FE, Peebles RS Jr., Blackwell TS. Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion. Am J Respir Crit Care Med 2010; 182:1273 - 81; http://dx.doi.org/10.1164/rccm.201001-0001OC; PMID: 20595227
- Stathopoulos GT, Zhu Z, Everhart MB, Kalomenidis I, Lawson WE, Bilaceroglu S, Peterson TE, Mitchell D, Yull FE, Light RW, et al. Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion. Am J Respir Cell Mol Biol 2006; 34:142 - 50; http://dx.doi.org/10.1165/rcmb.2005-0130OC; PMID: 16210694
- Stathopoulos GT, Psallidas I, Moustaki A, Moschos C, Kollintza A, Karabela S, Porfyridis I, Vassiliou S, Karatza M, Zhou Z, et al. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. J Natl Cancer Inst 2008; 100:1464 - 76; http://dx.doi.org/10.1093/jnci/djn325; PMID: 18840818
- Marazioti A, Kairi CA, Spella M, Giannou AD, Magkouta S, Giopanou I, Papaleonidopoulos V, Kalomenidis I, Snyder LA, Kardamakis D, et al. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion. PLoS One 2013; 8:e71207; http://dx.doi.org/10.1371/journal.pone.0071207; PMID: 23967166